Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture

Mary-Ann Pollmann, Qing Shao, Dale W Laird, Martin Sandig

Mutation analysis of the ATR gene in breast and ovarian cancer families

Katri Heikkinen, Virpi Mansikka, Sanna-Maria Karppinen, Katrin Rapakko, Robert Winqvist

Breast cancer and childhood anthropometry: emerging hypotheses?

Cecilia MK Magnusson, Andrew W Roddam

Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect

Emily Banks, Gillian Reeves, Valerie Beral, Diana Bull, Barbara Crossley, Moya Simmonds, Elizabeth Hilton, Stephen Bailey, Nigel Barrett, Peter Briers, Ruth English, Alan Jackson, Elizabeth Kutt, Janet Lavelle, Linda Rockall, Matthew G Wallis, Mary Wilson, Julietta Patnick

Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells

Agnes GSH van Rossum, Johan Gibcus, Jacqueline van der Wal, Ed Schuuring

Clinical trial update: International Breast Cancer Study Group

Karen N Price, Aron Goldhirsch, the International Breast Cancer Study Group

Expression analysis of candidate breast tumour suppressor genes on chromosome 16q

Tom van Wezel, Marcel Lombaerts, Eddy H van Roon, Katja Philippo, Hans J Baelde, Karoly Szuhai, Cees J Cornelisse, Anne-Marie Cleton-Jansen

Comprehensive copy number profiles of breast cancer cell model genomes

Ashleen Shadeo, Wan L Lam

Spontaneous apoptosis of blood dendritic cells in patients with breast cancer

Alberto Pinzon-Charry, Tammy Maxwell, Michael A McGuckin, Chris Schmidt, Colin Furnival, J Alejandro López

Co-expression of estrogen receptor-alpha and targets of estrogen receptor action in proliferating monkey mammary epithelial cells

Constantine Dimitrakakis, Jian Zhou, Jie Wang, Ludmila Matyakhina, Eva Mezey, Jesse Xiyu Wood, Daniel Wang, Carolyn Bondy

Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice

Eulalia de la Torre, Lilia Davel, María A Jasnis, Tomomi Gotoh, Eugenia de Lustig, María E Sales

The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells

Bruce E Elliott, Jalna A Meens, Sandip K SenGupta, Daniel Louvard, Monique Arpin

Update on inflammatory breast cancer

Florence Lerebours, Ivan Bieche, Rosette Lidereau

High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome

Klaus Schmitz, Florian Grabellus, Rainer Callies, Friedrich Otterbach, Jeremias Wohlschlaeger, Bodo Levkau, Rainer Kimmig, Kurt Schmid, Hideo Baba

The protective role of pregnancy in breast cancer

Jose Russo, Raquel Moral, Gabriela A Balogh, Daniel Mailo, Irma H Russo

Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival

Gem M Le, Cynthia D O'Malley, Sally L Glaser, Charles F Lynch, Janet L Stanford, Theresa HM Keegan, Dee W West

Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer

Ina H Benoy, Roberto Salgado, Hilde Elst, Peter Van Dam, Joost Weyler, Eric Van Marck, Simon Scharpé, Peter B Vermeulen, Luc Y Dirix

SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case–control study

Carmen Lilla, Angela Risch, Silke Kropp, Jenny Chang-Claude

Keystone symposium: The role of microenvironment in tumor induction and progression, Banff, Canada, 5–10 February 2005

Jamie L Bascom, Paraic A Kenny

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study

Patrick R Benusiglio, Fabienne Lesueur, Craig Luccarini, Donald M Conroy, Mitul Shah, Douglas F Easton, Nick E Day, Alison M Dunning, Paul D Pharoah, Bruce AJ Ponder

Accelerated partial breast irradiation: technically feasible but who will benefit?

Gillian Ross

Accelerated partial breast irradiation: the case for current use

Martin E Keisch

Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships

Kwang-Hwa Park, Sung-E Choi, Minseob Eom, Yup Kang

Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study

Heather J Baer, Graham A Colditz, Bernard Rosner, Karin B Michels, Janet W Rich-Edwards, David J Hunter, Walter C Willett

Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study

Sarah J Lord, Wendy J Mack, David Van Den Berg, Malcolm C Pike, Sue A Ingles, Christopher A Haiman, Wei Wang, Yuri R Parisky, Howard N Hodis, Giske Ursin

The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women

Karen G Montgomery, Jiun-Horng Chang, Dorota M Gertig, Gillian S Dite, Margaret R McCredie, Graham G Giles, Melissa C Southey, John L Hopper, Ian G Campbell

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry

Marta Salido, Ignasi Tusquets, Josep M Corominas, Marta Suarez, Blanca Espinet, Cristina Corzo, Meritxell Bellet, Xavier Fabregat, Sergi Serrano, Francesc Solé

Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study

Anna-Mária T？kés, Janina Kulka, Sándor Paku, ágnes Szik, Csilla Páska, Pál Novák, László Szilák, András Kiss, Krisztina B？gi, Zsuzsa Schaff

A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer

Stephanie E Nelson, Michael N Gould, John M Hampton, Amy Trentham-Dietz

Show me the genes – I will tell you who/how to treat!

Fatima Cardoso

A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology

Timothy L Lash, Brian D Bradbury, Jemma B Wilk, Ann Aschengrau

c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

Peter Fritz, Cristina M Cabrera, Jürgen Dippon, Andreas Gerteis, Wolfgang Simon, Walter E Aulitzky, Heiko van der Kuip

Clinical trial update: National Cancer Institute of Canada

Kathy Pritchard, Tim Whelan

How many genes are needed for early detection of breast cancer, based on gene expression patterns in peripheral blood cells?

Wuju Li

Dose-dense adjuvant chemotherapy for primary breast cancer

Monica Fornier, Larry Norton

Mammary stem cells, self-renewal pathways, and carcinogenesis

Suling Liu, Gabriela Dontu, Max S Wicha

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

Pia Wegman, Linda Vainikka, Olle St？l, Bo Nordenskj？ld, Lambert Skoog, Lars-Erik Rutqvist, Sten Wingren

CYP17 and breast cancer: no overall effect, but what about interactions?

Julian Little, Jacques Simard

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

Tara L Naylor, Joel Greshock, Yan Wang, Theresa Colligon, QC Yu, Virginia Clemmer, Tal Z Zaks, Barbara L Weber

What does an orphan G-protein-coupled receptor have to do with estrogen?

James M Rae, Michael D Johnson

Hormone replacement therapy, percent mammographic density and the sensitivity of mammography

AM Kavanagh, JN Cawson, GB Byrnes, GG Giles, G Marr, DM Gertig, J Hopper

Addition of granulocyte-colony stimulating factor (G-CSF) may further increase chemosensitive state in premenopausal node-positive breast cancer patients with induced angiogenesis after surgery

Kadri Altundag, Ozden Altundag, Mehmet Gunduz

Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study

Chi-Chen Hong, Bing-Kou Tang, Geoffrey L Hammond, David Tritchler, Martin Yaffe, Norman F Boyd

26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on clinical research

Rita Kramer

Articles selected in February 2004

Valerie Speirs

Articles selected in September 2004

Valerie Speirs

Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview

Chantal Guillemette, Alain Bélanger, Johanie Lépine

Frequency of the ATM IVS10-6T→G variant in Australian multiple-case breast cancer families

Geoffrey J Lindeman, Melody Hiew, Jane E Visvader, Jennifer Leary, Michael Field, Clara L Gaff, RJ McKinlay Gardner, Kevin Trainor, Glenice Cheetham, Graeme Suthers, Judy Kirk

Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study

Qiuyin Cai, Xiao-Ou Shu, Wanqing Wen, Jia-Rong Cheng, Qi Dai, Yu-Tang Gao, Wei Zheng

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705